Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil + propofol vs remifentanil + propofol for painless fiberoptic bronchoscopy in elderly patients
ChiCTR2400089391Phase 4Completed
- Sponsor
- The First Affiliated Hospital of the University of South China
- Start
- Sep 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bronchoscopy comparing Alfentanil + propofol with Remifentanil + propofol (2 arms). Primary endpoint: Incidence of respiratory depression. Started Sep 2024; status: completed.
02
Drugs
alfentanilremifentanilpropofol
03
Conditions
bronchoscopy
Beyond the preview
Go deeper on ChiCTR2400089391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089391.